Role of epoetin alfa in maintaining ribavirin doseAFDHAL, Nezam H.Gastroenterology clinics of North America. 2004, Vol 33, Num 1S, pp xviii-xix, issn 0889-8553, 12 p., SUPArticle

Is there a place for epoetin alfa in managing anemia during critical illness?GIVENS, Marlea; LAPOINTE, Marc.Clinical therapeutics. 2004, Vol 26, Num 6, pp 819-829, issn 0149-2918, 11 p.Article

Is there a possible survival benefit to increasing hemoglobin levels with epoetin alfa during chemotherapy?AAPRO, M; BAJETTA, E; FREUND, M et al.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 2, pp 20-28, issn 1359-6349, 9 p.Conference Paper

Epoetin alfa has potential efficacy in central nervous system disordersCERAMI, A; BRINES, M; CERAMI, C et al.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 2, pp 29-35, issn 1359-6349, 7 p.Conference Paper

Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patientsPUGLISI, Fabio; DEROMA, Laura; BECCAGLIA, Patrizia et al.Critical reviews in oncology/hematology. 2009, Vol 69, Num 2, pp 175-182, issn 1040-8428, 8 p.Article

Utilisation review of epoetin alfa in cancer patients at a cancer centre in SingaporeCHAN, A; LIM, L. L. C; TAO, M et al.Singapore medical journal. 2009, Vol 50, Num 4, pp 365-370, issn 0037-5675, 6 p.Article

Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysisJONES, Michael; IBELS, Lloyd; SCHENKEL, Brad et al.Kidney international. 2004, Vol 65, Num 3, pp 757-767, issn 0085-2538, 11 p.Article

Impact of Illegal Trade on the Quality of Epoetin Alfa in ThailandFOTIOU, Fotis; ARAVIND, Suresh; WANG, Ping-Ping et al.Clinical therapeutics. 2009, Vol 31, Num 2, pp 336-346, issn 0149-2918, 11 p.Article

A US Multicenter, Retrospective, Observational Study of Erythropoiesis-Stimulating Agent Utilization in Anemic, Critically ΙΙΙ Patients Admitted to the Intensive Care UnitBROPHY, Gretchen M; SHEEHAN, Valerie; SHAPIRO, Marc J et al.Clinical therapeutics. 2008, Vol 30, Num 12, pp 2324-2334, issn 0149-2918, 11 p.Article

Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy : Results of a multicenter randomised controlled trialSAVONIJE, J. H; VAN GROENINGEN, C. J; VAN BOCHOVE, A et al.European journal of cancer (1990). 2005, Vol 41, Num 11, pp 1560-1569, issn 0959-8049, 10 p.Article

Evaluating erythropoietic agents for the treatment of anaemia in the oncology settingGASCON, Pere.European journal of cancer (1990). 2005, Vol 41, Num 17, pp 2601-2612, issn 0959-8049, 12 p.Article

Stability of multidose, preserved formulation epoetin alfa in syringes for three and six weeksNAUGHTON, Cynthia A; DUPPONG, Lisa M; FORBES, Katie D et al.American journal of health-system pharmacy. 2003, Vol 60, Num 5, pp 464-468, issn 1079-2082, 5 p.Article

Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease : the PROMPT studyPROVENZANO, R; BHADURI, S; SINGH, A. K et al.Clinical nephrology. 2005, Vol 64, Num 2, pp 113-123, issn 0301-0430, 11 p.Article

The future of breast cancer: the role of prognostic factorsGRADISHAR, William J.Breast cancer research and treatment. 2005, Vol 89, pp S17-S26, issn 0167-6806, SUP1Article

A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy : An open-label, non randomized, pilot studySANTINI, Daniele; VINCENZI, Bruno; GROEGER, Angela M et al.Anticancer research. 2005, Vol 25, Num 1B, pp 669-674, issn 0250-7005, 6 p.Article

Epoetin alfa for treatment of anemia in HIV-infected: Patients past, present, and futureHENRY, David H; VOLBERDING, Paul A; LEITZ, Gerhard et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 37, Num 2, pp 1221-1227, issn 1525-4135, 7 p.Article

Once-weekly epoetin alfa for treating the anemia of chronic kidney diseasePROVENZANO, R; GARCIA-MAYOL, L; SUCHINDA, P et al.Clinical nephrology. 2004, Vol 61, Num 6, pp 392-405, issn 0301-0430, 14 p.Article

Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapyLITTLEWOOD, Timothy J; NORTIER, Johan; RAPOPORT, Bernardo et al.Hematological oncology. 2003, Vol 21, Num 4, pp 169-180, issn 0278-0232, 12 p.Article

Relationship between biopharmaceutical immunogenicity of epoetin alfa and pure red cell aplasiaSCHELLEKENS, Huub.Current medical research and opinion. 2003, Vol 19, Num 5, pp 433-434, issn 0300-7995, 2 p.Article

Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinomaABBREDERIS, Kathrin; BASSERMANN, Florian; SCHUHMACHER, Christoph et al.The Annals of thoracic surgery. 2006, Vol 82, Num 1, pp 293-297, issn 0003-4975, 5 p.Article

Optimizing the use of erythropoietic agents: pharmacokinetic and pharmacodynamic considerationsMACDOUGALL, Iain C.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 66-70, issn 0931-0509, SUP5Conference Paper

Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapySCHOUWINK, J. H; CODRINGTON, H; SLEEBOOM, H. P et al.European journal of cancer (1990). 2008, Vol 44, Num 6, pp 819-829, issn 0959-8049, 11 p.Article

Erythroblastopénies sous époétine (suite) = Red cell aplasie under epoetin alfa (continuation)La Revue Prescrire. 2003, Vol 23, Num 236, issn 0247-7750, p. 111Article

Clinical guidelines for the treatment of cancer-related anemiaKOELLER, J. M.Pharmacotherapy. 1998, Vol 18, Num 1, pp 156-169, issn 0277-0008Article

Alfa-epoietin and anaemia in gynaecological cancerDI COCCO, Barbara; SALESI, Nello; FABI, Alessandra et al.Anticancer research. 2004, Vol 24, Num 2C, pp 1287-1292, issn 0250-7005, 6 p.Article